FINKELSTEIN J J

PrivateCIK: 1125610

FINKELSTEIN J J (President and CEO) purchased 4.6% of their position (75K shares) of REGENERX BIOPHARMACEUTICALS INC on the open market

Open‑market purchase worth $15.0K — a small addition. The strongest form of insider conviction signal.

P · 1 purchase
InsiderFINKELSTEIN J JCIK 1125610
DirectorOfficer· President and CEO
Since Jul 2018
+187.50K
Net shares
Net buyer
$15.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
187.50K acquired
Non-Derivative Transactions1

Common Stock

Direct
P · Purchase

Shares

+75K

Price / share

$0.20

Trade value

$15K

% of position

4.6%
6/30/2021
1.64M1.71M
Total

Net shares

+75K

Net value

$15K

Derivative Transactions2

Series A Common Stock Warrant (right to buy)

Direct
P · Purchase
Converts to

Common Stock

56.25K shares

Shares

+56.25K

Strike price

0.24

Held after

56.25K

Exercisable

6/30/2021

Series B Common Stock Warrant (right to buy)

Direct
P · Purchase
Converts to

Common Stock

56.25K shares

Shares

+56.25K

Strike price

0.28

Held after

56.25K

Exercisable

6/30/2021
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)12

Common Stock Warrant (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

78.13K

Shares owned

78.13K

Exercise price

0.18

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

200K

Shares owned

200K

Exercise price

0.64

Expiration

Exercise window

Common Stock Warrant (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

20.88K

Shares owned

20.88K

Exercise price

0.45

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

500K

Shares owned

500K

Exercise price

0.30

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

650K

Shares owned

650K

Exercise price

0.21

Expiration

Exercise window

Convertible Promissory Note (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

104.17K

Shares owned

N/A

Exercise price

0.12

Expiration

Exercise window

Common Stock Warrant (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

78.13K

Shares owned

78.13K

Exercise price

0.18

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

150K

Shares owned

150K

Exercise price

0.28

Expiration

Exercise window

Convertible Promissory Note (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

27.84K

Shares owned

N/A

Exercise price

0.36

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

250K

Shares owned

250K

Exercise price

0.21

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

500K

Shares owned

500K

Exercise price

0.36

Expiration

Exercise window

Convertible Promissory Note (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

104.17K

Shares owned

N/A

Exercise price

0.12

Expiration

Exercise window

Total

Underlying

2.66M

Owned

2.43M

FINKELSTEIN J J — Insider Transaction (Form 4) Filed Jul 6, 2021 | Finecho